Hang Feng director and audit chair passes away

Hang Feng Technology Innovation Co., Ltd. reported the passing of board member Mr. Wong Yiu Kit Ernest on January 24, 2026.

Rhea-AI Filing Summary

Hang Feng Technology Innovation Co., Ltd. reported the passing of board member Mr. Wong Yiu Kit Ernest on January 24, 2026. He served on the Board, chaired the Audit Committee, and was a member of the Compensation and Nominating and Corporate Governance Committees.

The company notes it is entitled to Nasdaq phase-in periods for meeting majority independent board, audit committee, and independent nominations and compensation committee requirements. It intends to appoint a new independent director before the end of the applicable cure period to fill the vacancy created by Mr. Wong’s passing.

Insights

Corporate governance analyst

Director’s death creates a governance gap, but company plans timely replacement.

Hang Feng Technology Innovation Co., Ltd. discloses the death of Mr. Wong Yiu Kit Ernest, who held several key oversight roles, including chair of the Audit Committee and membership on compensation and nominating/governance committees. This temporarily reduces independent oversight at the board level.

The company cites eligibility for Nasdaq Phase-in Period relief on independence and committee requirements, which helps it remain within listing rules during the transition. It also states an intention to appoint a new independent director before the cure period ends, which, if completed as planned, would restore the prior committee structure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Hang Feng Technology Innovation Co., Ltd. (FOFO) announce in this 6-K filing?

Hang Feng Technology Innovation Co., Ltd. announced that director Mr. Wong Yiu Kit Ernest passed away on January 24, 2026. He served on the Board and several key committees, prompting a need to fill his roles with a new independent director.

Which board and committee roles did Mr. Wong hold at Hang Feng Technology Innovation (FOFO)?

Mr. Wong was a member of the Board of Directors, chair of the Audit Committee, and a member of both the Compensation Committee and the Nominating and Corporate Governance Committee. His passing creates vacancies in all these oversight positions for the company.

How does Nasdaq’s phase-in period apply to Hang Feng Technology Innovation Co., Ltd. (FOFO)?

The company states it is eligible for Nasdaq Listing Rule 5615(b) phase-in periods. These relate to majority independent board requirements, audit committee requirements, and independent nominations and compensation committee requirements, giving time to regain full compliance after Mr. Wong’s death.

How does Hang Feng Technology Innovation (FOFO) plan to address the board vacancy?

The company states it intends to appoint a new independent director before the end of the applicable cure period. This new director is expected to fill the vacancy resulting from Mr. Wong’s passing and help restore committee composition and independence levels.

Does Hang Feng Technology Innovation (FOFO) remain compliant with Nasdaq rules after the director’s death?

The company notes it is eligible for phase-in periods under Nasdaq Listing Rule 5615(b). These phase-in and cure periods allow time to re-establish majority independent board status and committee independence following Mr. Wong’s death, while remaining within Nasdaq’s framework.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/28/2026 - 04:05 PM Learn about SEC filing dates

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of January 2026

Commission File Number: 001-42835

HANG FENG TECHNOLOGY INNOVATION CO., LTD.

(Exact name of registrant as specified in its charter)

Unit 2806, 28/F, Tower One, Lippo Centre

No. 89 Queensway, Hong Kong

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☒      Form 40-F ☐

Explanatory Note

Hang Feng Technology Innovation Co., Ltd. (the “Company”) is saddened to report that Mr. Wong Yiu Kit Ernest, a member of the Company’s Board of Directors (the “Board”), the chair of the Board’s Audit Committee, and a member of the Compensation Committee and Nominating and Corporate Governance Committee, passed away on January 24, 2026. The Company is grateful for Mr. Wong’s dedication and service to the Company. The Company’s management and Board extends their sincere condolences to Mr. Wong’s family.

Pursuant to Nasdaq Listing Rule 5615(b), the Company is eligible for certain phase-in periods (the “Phase-in Period”) before it is required to fully comply with provisions of the majority independent board requirement of Nasdaq Listing Rule 5605(b), the audit committee requirements for Nasdaq Listing Rule 5605(c)(2), and the independent nominations and compensation committee requirements of Nasdaq Listing Rules 5605(d)(2) and 5605(e)(1)(B). The Company intends to appoint a new independent director prior to the end of the cure period to fill in the vacancy resulted from Mr. Wong’s passing.

1

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Hang Feng Technology Innovation Co., Ltd.
Date: January 28, 2026	By:	/s/ XU Zhiheng
	Name:	XU Zhiheng
	Title:	Chief Executive Officer

2